Nature’s Sunshine Products (NASDAQ:NATR) EVP Sells 1,700 Shares

Nature’s Sunshine Products, Inc. (NASDAQ:NATR) EVP Bryant Yates sold 1,700 shares of the business’s stock in a transaction dated Friday, December 12th. The shares were sold at an average price of $22.29, for a total value of $37,893.00. Following the transaction, the executive vice president owned 98,604 shares in the company, valued at $2,197,883.16. This represents a 1.69% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Nature’s Sunshine Products Stock Performance

Shares of NASDAQ:NATR traded down $0.84 during trading on Tuesday, hitting $22.39. 69,380 shares of the stock were exchanged, compared to its average volume of 81,557. The company has a market capitalization of $391.84 million, a price-to-earnings ratio of 27.78 and a beta of 0.97. Nature’s Sunshine Products, Inc. has a 1-year low of $11.01 and a 1-year high of $24.12. The company’s fifty day simple moving average is $17.80 and its 200-day simple moving average is $16.40.

Nature’s Sunshine Products (NASDAQ:NATR) last issued its earnings results on Thursday, November 6th. The company reported $0.36 EPS for the quarter, beating analysts’ consensus estimates of $0.18 by $0.18. The business had revenue of $88.99 million during the quarter, compared to analyst estimates of $119.39 million. Nature’s Sunshine Products had a return on equity of 10.86% and a net margin of 3.18%.

Institutional Investors Weigh In On Nature’s Sunshine Products

A number of large investors have recently bought and sold shares of NATR. MTM Investment Management LLC acquired a new position in Nature’s Sunshine Products in the second quarter worth $30,000. CWM LLC raised its holdings in shares of Nature’s Sunshine Products by 147.0% in the third quarter. CWM LLC now owns 2,075 shares of the company’s stock valued at $32,000 after buying an additional 1,235 shares during the last quarter. Raymond James Financial Inc. acquired a new position in Nature’s Sunshine Products during the 2nd quarter worth about $37,000. Centiva Capital LP bought a new stake in Nature’s Sunshine Products during the 3rd quarter worth about $157,000. Finally, Algert Global LLC acquired a new stake in Nature’s Sunshine Products in the 3rd quarter valued at about $160,000. 79.40% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several analysts have recently weighed in on NATR shares. Weiss Ratings reiterated a “hold (c+)” rating on shares of Nature’s Sunshine Products in a research report on Monday, December 8th. DA Davidson lifted their price objective on Nature’s Sunshine Products from $21.00 to $23.00 and gave the company a “buy” rating in a report on Monday, November 10th. Two investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $22.50.

About Nature’s Sunshine Products

Nature’s Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.